{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:34:25Z","timestamp":1761237265071},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1053\/j.seminoncol.2003.12.008","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"33-37","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S2","title":["Clearing Minimal Residual Disease with Rituximab Consolidation Therapy"],"prefix":"10.1053","volume":"31","author":[{"given":"Wolfram","family":"Brugger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2003.12.008_BIB1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB3","first-page":"674a","article-title":"Clinical characteristics and response to chemotherapy of mantle cell lymphoma\u2013Results of a European survey","volume":"88","author":"Hiddemann","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1997.15.2.445","article-title":"High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin\u2019s lymphoma","volume":"15","author":"Bierman","year":"1997","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.12.008_BIB5","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1023\/A:1008339921975","article-title":"The CUP trial","volume":"11","author":"Schouten","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bmt.1701051","article-title":"Should we purge?","volume":"21","author":"Bensinger","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/stem.150297","article-title":"Purging peripheral blood progenitor cell grafts from lymphoma cells","volume":"15","author":"Paulus","year":"1997","journal-title":"Stem Cells"},{"issue":"suppl 14","key":"10.1053\/j.seminoncol.2003.12.008_BIB8","first-page":"115","article-title":"Stem cell function and engraftment is not affected by \u201cin vivo purging\u201d with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin\u2019s lymphoma","volume":"26","author":"Buckstein","year":"1999","journal-title":"Semin Oncol"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB9","first-page":"141a","article-title":"Rituximab permits in-vivo purging and collection of tumor free stem cells prior to autologous transplantation for B-cell non Hodgkin\u2019s lymphoma","volume":"94","author":"Goldberg","year":"1999","journal-title":"Blood"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB10","first-page":"184a","article-title":"Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (peripheral blood SCT) in B-cell non-Hodgkin\u2019s lymphomas (NHL). A single institution study","volume":"96","author":"Haioun","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","article-title":"In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and rituximab for autografting in patients with non-Hodgkin\u2019s lymphoma","volume":"109","author":"Voso","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","article-title":"Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma","volume":"96","author":"Magni","year":"2000","journal-title":"Blood"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB13","first-page":"738a","article-title":"Rituximab does not reduce CD34+ cell yield in patients mobilised with etoposide plus G-CSF","volume":"98","author":"Bolwell","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB14","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V78.6.1552.1552","article-title":"Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis","volume":"78","author":"Zelenetz","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB15","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","article-title":"All advanced stage non-Hodgkin\u2019s lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment","volume":"78","author":"Gribben","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB16","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB17","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.12.008_BIB18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.V99.3.856","article-title":"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma","volume":"99","author":"Rambaldi","year":"2002","journal-title":"Blood"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB19","first-page":"647a","article-title":"High dose therapy\/ASCT consolidated with rituximab and or alpha interferon immunotherapy for relapsed follicular lymphoma prolongs progression free survival and achieves durable molecular remissions","volume":"100","author":"Buckstein","year":"2002","journal-title":"Blood"},{"issue":"abstr","key":"10.1053\/j.seminoncol.2003.12.008_BIB20","first-page":"780a","article-title":"Intensive chemotherapy and autologous stem cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle cell lymphoma","volume":"100","author":"Mangel","year":"2002","journal-title":"Blood"},{"issue":"abstr 2532","key":"10.1053\/j.seminoncol.2003.12.008_BIB21","first-page":"644a","article-title":"Treatment of follicular and mantle cell lymphoma with rituximab after high-dose chemotherapy and autologous blood stem cell transplantation","volume":"11","author":"Brugger","year":"2002","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403006468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403006468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:03:56Z","timestamp":1586538236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403006468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":21,"alternative-id":["S0093775403006468"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2003.12.008","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}